The American Cancer Society now recommends clearer PSA screening schedules, with earlier annual testing for Black men and certain men with a family history, following stronger evidence that screening can reduce prostate cancer deaths.
A boy, 15, needed emergency treatment after drinking a beverage containing cod collagen, even though skin prick tests for several fish allergies were negative. Experts say fish derived proteins in drinks and supplements demand close label scrutiny.
Sunharbo reduced ischemic stroke risk by 26% in a phase 3 trial, but bleeding concerns affected some patients. Cardiologist Richard Kovacs says treatment discussions should begin soon after a qualifying stroke because trial participants received the drug within 72 hours.
Stroke incidence rose sharply among adults ages 20 to 54, while researchers documented increases in major risk factors and substance use. Experts stressed prevention, screening and immediate emergency care when warning signs appear.
Studies suggest GLP-1 medications could lower certain cancer risks and recurrence rates, but conflicting findings and the absence of dedicated randomized trials leave researchers seeking clearer answers about weight loss, immune responses and long term outcomes.
Scientists have created enamel producing organoids and developing tooth structures using human and animal cells, raising hopes for biological fillings and replacement teeth. Human treatment remains years away, with further research and animal studies still required.
Sleeping in can ease some effects of short sleep, but large schedule shifts may disrupt sleep pressure and the body clock. Research points to roughly one to two extra hours as a potential sweet spot for most people.
After an Alzheimer’s diagnosis in August 2025, Chesley “Sully” Sullenberger and his wife are revealing the quiet memory and behavior changes they initially missed while urging families to seek testing when something feels unusual.
Students for Life of America has given the FDA 60 days to address allegations that the agency failed to complete required environmental consultations before approving mifepristone, or face a lawsuit over possible risks to waterways and wildlife.
An analysis of nearly 8.8 million adults linked each additional 100 grams of ultra-processed food consumed daily to increased risks of cardiovascular events, cancer, death, metabolic syndrome and diabetes, although researchers could not establish direct causation.
Packaged kratom was found during investigations into two University of Mississippi student deaths, prompting expert warnings about breathing suppression, dependence, withdrawal and concentrated 7-OH products, even as authorities have not linked the substance to either death.
Brad Pitt’s restrained return to alcohol highlights an evolving medical view of recovery, where remission and reduced drinking may count alongside abstinence, even as experts warn that moderation is not appropriate or safe for everyone.
Sara Bareilles channels personal loss, anxiety and fertility struggles into “Good Grief,” an album that treats mourning not as an enemy, but as a sacred practice capable of revealing love, comfort, mystery and even joy.
A new analysis suggests eating about three daily servings of whole grains may improve several cardiovascular and metabolic health markers, but experts say replacing refined grains and maintaining a healthy overall dietary pattern matter more than chasing a single target.
A Colorado science teacher’s chance discovery in the Hell Creek Formation revealed the first known T. rex trackway, preserving five enormous footprints and new evidence about how the predator moved 66.5 million years ago.
Lead in ancient ink may help researchers select and decipher fragile Herculaneum scrolls, while recreated papyri could provide valuable training material for artificial intelligence tasked with recovering writings buried inside carbonized artifacts.
Testosterone use among women is climbing rapidly, but the absence of an approved product specifically dosed for them is fueling pharmacy refusals, safety concerns, added costs and calls for stronger FDA evaluation.